Glenmark Generics Gets U.S. FDA Nod for Cirrhosis Drug

Glenmark Generics has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Ursodiol tablets used in treatment of patients with primary biliary cirrhosis (PBC).
Moneycontrol